Acute myocardial infarction: susceptibility-weighted cardiac MRI for the detection of reperfusion haemorrhage at 1.5 T.

AIM: To assess whether susceptibility-weighted imaging (SWI) provides better image contrast for the detection of haemorrhagic ischaemia-reperfusion injury in the heart. MATERIALS AND METHODS: Thirty patients (all men; mean age 53 years) underwent cardiac magnetic resonance imaging (MRI) within 7 days of primary percutaneous intervention for acute ST elevation myocardial infarction (STEMI). Multiple gradient-echo T2* sequences with magnitude and phase reconstructions were acquired. A high-pass filtered phase map was used to create a mask for the SWI reconstructions. The difference in image contrast was assessed in those patients with microvascular obstruction. A mixed effects regression model was used to test the effect of echo time and reconstruction method on phase and contrast-to-noise ratio (CNR). Medians and interquartile ranges (IQR) are reported. RESULTS: T2* in haemorrhagic infarcts was shorter than in non-haemorrhagic infarcts (33.5 ms [24.9-43] versus 49.9 ms [44.6-67.6]; p=0.0007). The effect of echo time on phase was significant (p<0.0001), as was the effect of haemorrhage on phase (p=0.0016). SWI reconstruction had a significant effect on the CNR at all echo times (echoes 1-5, p<0.0001; echo 6, p=0.01; echo 7, p=0.02). The median echo number at which haemorrhage was first visible was less for SWI compared to source images (echo 2 versus echo 5, p=0.0002). CONCLUSION: Cardiac SWI improves the contrast between myocardial haemorrhage and the surrounding tissue following STEMI and has potential as a new tool for identifying patients with ischaemia-reperfusion injury.

Sexual dimorphism in relation to adipose tissue and intrahepatocellular lipid deposition in early infancy.

Sexual dimorphism in adiposity is well described in adults, but the age at which differences first manifest is uncertain. Using a prospective cohort, we describe longitudinal changes in directly measured adiposity and intrahepatocellular lipid (IHCL) in relation to sex in healthy term infants. At median ages of 13 and 63 days, infants underwent quantification of adipose tissue depots by whole-body magnetic resonance imaging and measurement of IHCL by in vivo proton magnetic resonance spectroscopy. Longitudinal data were obtained from 70 infants (40 boys and 30 girls). In the neonatal period girls are more adipose in relation to body size than boys. At follow-up (median age 63 days), girls remained significantly more adipose. The greater relative adiposity that characterises girls is explained by more subcutaneous adipose tissue and this becomes increasingly apparent by follow-up. No significant sex differences were seen in IHCL. Sex-specific differences in infant adipose tissue distribution are in keeping with those described in later life, and suggest that sexual dimorphism in adiposity is established in early infancy.

Early nutritional determinants of intrahepatocellular lipid deposition in preterm infants at term age.

BACKGROUND: We have previously shown that by term age, preterm infants have elevated intrahepatocellular lipid (IHCL) content and altered regional adiposity, both of which are risk factors for cardiometabolic illness in adult life. Preterm nutritional intake is a plausible determinant of these aberrant trajectories of development. OBJECTIVE: We aimed to establish if macronutritional components of the preterm diet were determinants of IHCL deposition measured at term equivalent age, using (1)H Magnetic Resonance spectroscopy (MRS). METHODS: Prospective observational case-control study in a single UK neonatal unit. (1)H MR spectra were acquired from 18 preterm infants (<32 weeks gestational age at birth) at term age and 31 healthy term infants, who acted as a control group. Neonatal nutritional information was collected from birth to 34(+6) weeks postmenstrual age. RESULTS: IHCL (median, interquartile range) was significantly higher in preterm-at-term infants compared with term-born infants: 0.735, 0-1.46 versus 0.138, 0-0.58; P=0.003. In preterm infants, IHCL was positively correlated with lipid intake in the first week of life (r=0.52, P=0.04). CONCLUSIONS: This study confirms our previous observation of elevated IHCL in preterm infants at term and suggests that early lipid intake may be a determinant. Future work is warranted to establish the clinical relevance and the role of nutritional intervention in attenuating or exacerbating this effect in preterm infants.

Estimation of abdominal fat compartments by bioelectrical impedance: the validity of the ViScan measurement system in comparison with MRI.

BACKGROUND/OBJECTIVES: Abdominal obesity, more specifically increased intra-abdominal adipose tissue, is strongly associated with increased risk of metabolic disease. Bioelectrical impedance analysis (BIA) has been proposed as a potential method of determining individual abdominal fat compartments in the form of the commercially available ViScan measurement system (Tanita Corporation), but it has yet to be independently validated. The objective of this study was to analyse the validity of the ViScan to assess adult abdominal adiposity across a range of body fatness. SUBJECTS/METHODS: This was a cross-sectional study with 74 participants (40 females and 34 males with body mass index (BMI) between 18.5 and 39.6 kg/m(2)). Total abdominal adipose tissue, subcutaneous abdominal adipose tissue (SAAT) and intra-abdominal adipose tissue (IAAT) were measured by magnetic resonance imaging (MRI). In addition, intra-hepatocellular lipid was obtained by magnetic resonance spectroscopy. Estimates of abdominal adiposity (total and compartmental) were obtained from BIA and anthropometry. RESULTS: ViScan-derived percentage trunk fat strongly and significantly related with total abdominal adipose tissue and SAAT in both lean and overweight/obese individuals, and categorized individuals reliably in terms of total abdominal fat. ViScan-derived 'visceral' fat correlated significantly with IAAT but the strength of this relationship was much weaker in overweight/obese individuals, particularly those with higher SAAT, leading to less reliable classification of individuals for IAAT. CONCLUSIONS: The ViScan may serve as a useful tool for predicting total abdominal fat, but prediction of visceral fat (IAAT) may be limited, especially in abdominally obese individuals.

Reduction of total lung capacity in obese men: comparison of total intrathoracic and gas volumes.

Restriction of total lung capacity (TLC) is found in some obese subjects, but the mechanism is unclear. Two hypotheses are as follows: 1) increased abdominal volume prevents full descent of the diaphragm; and 2) increased intrathoracic fat reduces space for full lung expansion. We have measured total intrathoracic volume at full inflation using magnetic resonance imaging (MRI) in 14 asymptomatic obese men [mean age 52 yr, body mass index (BMI) 35-45 kg/m2] and 7 control men (mean age 50 yr, BMI 22-27 kg/m2). MRI volumes were compared with gas volumes at TLC. All measurements were made with subjects supine. Obese men had smaller functional residual capacity (FRC) and FRC-to-TLC ratio than control men. There was a 12% predicted difference in mean TLC between obese (84% predicted) and control men (96% predicted). In contrast, differences in total intrathoracic volume (MRI) at full inflation were only 4% predicted TLC (obese 116% predicted TLC, control 120% predicted TLC), because mediastinal volume was larger in obese than in control [heart and major vessels (obese 1.10 liter, control 0.87 liter, P=0.016) and intrathoracic fat (obese 0.68 liter, control 0.23 liter, P<0.0001)]. As a consequence of increased mediastinal volume, intrathoracic volume at FRC in obese men was considerably larger than indicated by the gas volume at FRC. The difference in gas volume at TLC between the six obese men with restriction, TLC<80% predicted (OR), and the eight obese men with TLC>80% predicted (ON) was 26% predicted TLC. Mediastinal volume was similar in OR (1.84 liter) and ON (1.73 liter), but total intrathoracic volume was 19% predicted TLC smaller in OR than in ON. We conclude that the major factor restricting TLC in some obese men was reduced thoracic expansion at full inflation.

Fat distribution in men of different waist girth, fitness level and exercise habit.

BACKGROUND: The risk of chronic disease is lower in obese men who are fit and active than obese men who are unfit and inactive. METHODS/OBJECTIVES: Magnetic resonance imaging and spectroscopy were used to assess total and regional adipose tissue in 13 men who were slim, fit and active (the slim-fit), in 12 men who were slim, unfit and inactive (the slim-unfit), in 13 men who were fat, fit and active (the fat-fit) and in 12 men who were fat, unfit and inactive (the fat-unfit), in order to investigate the hypothesis that visceral fat and liver fat are lower in the fat-fit than the fat-unfit. Waist girth was used to distinguish slim men (< or =90 cm) and fat men (> or =100 cm). Maximal oxygen consumption was used to identify fit men (above average for age) and unfit men (average or below for age). Fit men reported at least 60 min of vigorous aerobic activity per week and unfit men reported no regular moderate or vigorous activity in the last 2 years. RESULTS: Total fat was not significantly different in the slim-fit and the slim unfit, but the proportion of internal fat was significantly lower (P<0.05) and the proportion of visceral fat was almost significantly lower (P=0.06) in the slim-fit than all other groups. Total fat was not significantly different in the fat-fit and the fat-unfit, but visceral fat and liver fat were significantly lower in the fat-fit than the fat-unfit (P<0.01). Waist girth and years of exercise explained 84% of the variance in total fat, waist girth and maximal oxygen consumption explained 70% of the variance in visceral fat, and waist girth alone explained 25% of the variance in liver fat. CONCLUSION: Chronic disease risk may be lower because visceral fat and liver fat are lower in men who are fat, fit and active.

Incidental findings in healthy control research subjects using whole-body MRI.

AIM: Magnetic resonance imaging (MRI) is a powerful clinical tool used increasingly in the research setting. We aimed to assess the prevalence of incidental findings in a sequential cohort of healthy volunteers undergoing whole-body MRI as part of a normal control database for imaging research studies. MATERIALS AND METHODS: 148 healthy volunteers (median age 36 years, range 21-69 years; 63.5% males, 36.5% females) were enrolled into a prospective observational study at a single hospital-based MRI research unit in London, UK. Individuals with a clinical illness, treated or under investigation were excluded from the study. RESULTS: 43 (29.1%) scans were abnormal with a total of 49 abnormalities detected. Of these, 20 abnormalities in 19 patients (12.8%) were of clinical significance. The prevalence of incidental findings increased significantly with both increasing age and body mass index (BMI). Obese subjects had a fivefold greater risk of having an incidental abnormality on MRI (OR 5.4, CI 2.1-14.0). CONCLUSIONS: This study showed that more than one quarter of healthy volunteers have MR-demonstrable abnormalities. There was an increased risk of such findings in obese patients. This has ethical and financial implications for future imaging research, particularly with respect to informed consent and follow-up of those with abnormalities detected during the course of imaging studies.